InvestorsHub Logo
Followers 90
Posts 17892
Boards Moderated 0
Alias Born 09/06/2006

Re: dstock07734 post# 666014

Monday, 01/22/2024 11:48:02 AM

Monday, January 22, 2024 11:48:02 AM

Post# of 724258

If you check carefully, you can see that Merck has no vaccines in any form pending for approval. For Merck to start massive constructions of vaccine manufacturing facilities with crazy working hours and hire all high-caliber talents in the area of immunology, cell therapy, and cell manufacturing, Merck must have seen something definitive. There is nothing more definitive than DCVax-L. Period!


Merck was the worlds largest vaccine manufacture pre COVID. They had over $10B in vaccine sales last year. They are doing extensive R&D in addition to having mfg ops.

On the specific assertion of no pending approvals, That is beyond belie for a company that gets several approved every year, .This is one example just accepted for priority review last month

The deal with Daiichi which has the FDA approved oral CSF1R inhibitor, the only one on this planet also gives us the indication that Merck is aiming at including plx3397 in the further combination trial which has been going on for several years at UCLA.


The Diachi deal was specifically for ADCs, did not include 3397.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News